Differential effects of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on prostate cancer cell signaling and death

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 4287-4298

  Kaushik, Maiti ^a   Da, Young Oh ^a   Jung, Sun Moon ^a   Sujata, Acharjee ^a   Jian, Hua Li ^a   Dong, Gyu Bai ^a   Hee Sae, Park ^a   Keesook, Lee ^a   Young, Chul Lee ^a   Neon, Chul Jung ^b   Kyungjin, Kim ^b   Hubert, Vaudry ^c   Hyuk, Bang Kwon ^a   Jae, Young Seong ^a,d  

^a Chonnam National University   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITÉ DE ROUEN   (France)

^d Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AZIDOBENZOYL DEXTRO LYSINE; CALCIUM ION; CETRORELIX; DEXTRO LYSINE; GONADORELIN 1; GONADORELIN 2; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; HORMONE BINDING PROTEIN; INOSITOL TRISPHOSPHATE RECEPTOR; IODINE 125; RECEPTOR; RYANODINE RECEPTOR; TRPTORELIX 1; UNCLASSIFIED DRUG;

AGONIST; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CANCER CELL; CANCER MORTALITY; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

APOPTOSIS; CALCIUM; GONADOTROPIN-RELEASING HORMONE; HUMANS; INOSITOL PHOSPHATES; MALE; PHOTOAFFINITY LABELS; PROSTATIC NEOPLASMS; RECEPTORS, LHRH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SIGNAL TRANSDUCTION;

EID: 23044486562     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2004-1894     Document Type: Article

References (52)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M 2001 Cancer statistics, 2001. CA Cancer J Clin 51:15-36
2. Navarro D, Luzardo OP, Fernandez L, Chesa N, Diaz-Chico BN 2002 Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 81:191-201
3. Eisenberger MA, O'Dwyer PJ, Friedman MA 1986 Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma. J Clin Oncol 4:414-424
4. Comaru-Schally AM, Brannan W, Schally AV, Colcolough M, Monga M 1998 Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia. J Clin Endocrinol Metab 83:3826-3831
5. Cook T, Sheridan WP 2000 Development of GnRH antagonists for prostate cancer: new approaches to treatment. Oncologist 5:162-168
6. White RB, Eisen JA, Kasten TL, Fernald RD 1998 Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci USA 95:305-309
7. Fernald RD, White RB 1999 Gonadotropin-releasing hormone genes: phylogeny, structure, and functions. Front Neuroendocrinol 20:224-240
8. Siler-Khodr TM, Grayson M 2001 Action of chicken II GnRH on the human placenta. J Clin Endocrinol Metab 86:804-810
9. Cheon KW, Lee HS, Parhar IS, Kang IS 2001 Expression of the second isoform of gonadotrophin-releasing hormone (GnRH-II) in human endometrium throughout the menstrual cycle. Mol Hum Reprod 7:447-452
10. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y 2002 Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 62:1036-1044
11. Kang SK, Tai CJ, Nathwani PS, Leung PC 2001 Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid in human granulosa-luteal cells. Endocrinology 142:182-192
12. Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M 2002 The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 8:1421-1426
13. Moretti RM, Marelli MM, Dondi D, Poletti A, Martini L, Motta M, Limonta P 1996 Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145. J Clin Endocrinol Metab 81:3930-3937
14. Marelli MM, Moretti RM, Dondi D, Motta M, Limonta P 1999 Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells. Endocrinology 140:329-334
15. Limonta P, Moretti RM, Marelli MM, Dondi D, Parenti M, Motta M 1999 The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway. Endocrinology 140:5250-5256
16. Grosse R, Schmid A, Schoneberg T, Herrlich A, Muhn P, Schultz G, Gudermann T 2000 Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins. J Biol Chem 275:9193-9200
17. Emons G, Grundker C, Gunthert AR, Westphalen S, Kavanagh J, Verschraegen C 2003 GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer 10:291-299
18. Illing N, Troskie BE, Nahorniak CS, Hapgood JP, Peter RE, Millar RP 1999 Two gonadotropin-releasing hormone receptor subtypes with distinct ligand selectivity and differential distribution in brain and pituitary in the goldfish (Carassius auratus). Proc Natl Acad Sci USA 96:2526-2531
19. Wang L, Bogerd J, Choi HS, Seong JY, Soh JM, Chun SY, Blomenrohr M, Troskie BE, Millar RP, Yu WH, McCann SM, Kwon HB 2001 Three distinct types of GnRH receptor characterized in the bullfrog. Proc Natl Acad Sci USA 98:361-366
20. Millar R, Lowe S, Conklin D, Pawson A, Maudsley S, Troskie B, Ott T, Millar M, Lincoln G, Sellar R, Faurholm B, Scobie G, Kuestner R, Terasawa E, Katz A 2001 A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proc Natl Acad Sci USA 98:9636-9641
21. Neill JD, Duck LW, Sellers JC, Musgrove LC 2001 A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates. Biochem Biophys Res Commun 282:1012-1018
22. Wang AF, Li JH, Maiti K, Kim WP, Kang HM, Seong JY, Kwon HB 2003 Preferential ligand selectivity of the monkey type-II gonadotropin-releasing hormone (GnRH) receptor for GnRH-2 and its analogs. Mol Cell Endocrinol 209:33-42
23. Faurholm B, Millar RP, Katz AA 2001 The genes encoding the type II gonadotropin-releasing hormone receptor and the ribonucleoprotein RBM8A in humans overlap in two genomic loci. Genomics 78:15-18
24. Neill JD 2002 GnRH and GnRH receptor genes in the human genome. Endocrinology 143:737-743
25. Morgan K, Conklin D, Pawson AJ, Sellar R, Ott TR, Millar RP 2003 A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 144:423-436
26. Wang L, Oh DY, Bogerd J, Choi HS, Ahn RS, Seong JY, Kwon HB 2001 Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling. Endocrinology 142:4015-4025
27. Seong JY, Wang L, Oh DY, Yun O, Maiti K, Li JH, Soh JM, Choi HS, Kim K, Vaudry H, Kwon HB 2003 Ala/Thr(201) in extracellular loop 2 and leu/phe(290) in transmembrane domain 6 of type 1 frog gonadotropin-releasing hormone receptor confer differential ligand sensitivity and signal transduction. Endocrinology 144:454-466
28. Oh DY, Wang L, Ahn RS, Park JY, Seong JY, Kwon HB 2003 Differential G protein coupling preference of mammalian and nonmammalian gonadotropin-releasing hormone receptors. Mol Cell Endocrinol 205:89-98
29. Maiti K, Li JH, Wang AF, Acharjee S, Kim WP, Im WB, Kwon HB, Seong JY 2003 GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors. Mol Cells 16:173-179
30. Wang C, Yun O, Maiti K, Oh DY, Kim KK, Chae CH, Lee CJ, Seong JY, Kwon HB 2004 Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-II. Mol Endocrinol 18:105-116
31. Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladaga LE, Merchant DJ 1989 Cytogenetic analysis of four primary prostatic cultures. Cancer Genet Cytogenet 37:241-248
32. Nakhla AM, Rosner W 1994 Characterization of ALVA-41 cells, a new human prostatic cancer cell line. Steroids 59:586-589
33. Iizumi T, Yazaki T, Kanoh S, Kondo I, Koiso K 1987 Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J Urol 137:1304-1306
34. Acharjee S, Maiti K, Soh JM, Im WB, Seong JY, Kwon HB 2002 Differential desensitization and internalization of three different bullfrog gonadotropin-releasing hormone receptors. Mol Cell 14:101-107
35. Davidson JS, Assefa D, Pawson A, Davies P, Hapgood J, Becker I, Flanagan C, Roeske R, Millar R 1997 Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry 36:12881-12889
36. van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ 2001 TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res 61:6340-6344
37. Mulvaney JM, Roberson MS 2000 Divergent signaling pathways requiring discrete calcium signals mediate concurrent activation of two mitogen-activated protein kinases by gonadotropin-releasing hormone. J Biol Chem 275:14182-14189
38. Preston GA, Barrett JC, Biermann JA, Murphy E 1997 Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Res 57:537-542
39. Wertz IE, Dixit VM 2000 Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J Biol Chem 275:11470-11477
40. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA 90:4986-4990
41. 2+ release channel of sarcoplasmic reticulum. J Biol Chem 261:6300-6306
42. Sutko JL, Airey JA, Welch W, Ruest L 1997 The pharmacology of ryanodine and related compounds. Pharmacol Rev 49:53-98
43. Kraus S, Levy G, Hanoch T, Naor Z, Seger R 2004 Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways. Cancer Res 64:5736-5744
44. Grundker C, Emons G 2003 Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. Reprod Biol Endocrinol 1:65
45. 2+-ATPases 2B involvement in human prostate cancer cell growth control. J Biol Chem 276:47608-47614
46. Matyash M, Matyash V, Nolte C, Sorrentino V, Kettenmann H 2002 Requirement of functional ryanodine receptor type 3 for astrocyte migration. FASEB J 16:84-86
47. Choi KC, Auersperg N, Leung PC 2001 Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells. J Clin Endocrinol Metab 86:5075-5078
48. Bahk JY, Hyun JS, Lee H, Kim MO, Cho GJ, Lee BH, Choi WS 1998 Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells. Urol Res 26:259-264
49. Yano T, Pinski J, Halmos G, Szepeshazi K, Groot K, Schally AV 1994 Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75. Proc Natl Acad Sci USA 91:7090-7094
50. Yano T, Pinski J, Radulovic S, Schally AV 1994 Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 91:1701-1705
51. Tang X, Yano T, Osuga Y, Matsumi H, Yano N, Xu J, Wada O, Koga K, Kugu K, Tsutsumi O, Schally AV, Taketani Y 2002 Cellular mechanisms of growth inhibition of human epithelial ovarian cancer cell line by LH-releasing hormone antagonist Cetrorelix. J Clin Endocrinol Metab 87:3721-3727
52. Mariot P, Prevarskaya N, Roudbaraki MM, Le Bourhis X, Van Coppenolle F, Vanoverberghe K, Skryma R 2000 Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. Prostate 43:205-214